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In the 1960s, ablative stereotactic surgery was em-
ployed for a variety of movement disorders and psy-
chiatric conditions. Although largely abandoned in
the 1970s because of highly effective drugs, such as
levodopa for Parkinson’s disease (PD), and a reaction
against psychosurgery, the field has undergone a
virtual renaissance, guided by a better understanding
of brain circuitry and the circuit abnormalities underly-
ing movement disorders such as PD and neuropsychi-
atric conditions, such as obsessive compulsive disor-
der. High-frequency electrical deep brain stimulation
(DBS) of specific targets, introduced in the early
1990s for tremor, has gained widespread acceptance
because of its less invasive, reversible, and adjustable
features and is now utilized for an increasing number
of brain disorders. This review summarizes the ratio-
nale behind DBS and the use of this technique for
a variety of movement disorders and neuropsychiatric
diseases.
Introduction
Stereotactic surgery for movement disorders, especially
ablative approaches for Parkinson’s disease (PD) and
tremor, was commonplace in the 1950s and 1960s,
along with psychosurgery, i.e., interventions to treat ab-
normal and even violent behavior with focal lesions of
different brain regions. Stereotactic surgery greatly de-
creased for movement disorders with the introduction
of levodopa for PD in the 1960s, and psychosurgery
came under severe criticism and was abandoned in
the 1970s. However, it soon became clear that patients
on levodopa and other antiparkinsonian drugs often de-
velop significant drug-induced complications, such as
involuntary movements (dyskinesias), motor fluctua-
tions, hallucinations, and psychosis, which limit the
usefulness of these drugs.
These findings, combined with a better understanding
of the pathophysiologic basis of movement disorders
and neuropsychiatric conditions, rekindled interest in
the earlier surgical approaches. With significantly im-
proved techniques, surgeons first revisited the use of
ablative procedures. More recently, however, electrical
deep brain stimulation (DBS) has largely replaced abla-
tion, because it is less invasive, reversible, and adjust-
able. In this review, we will survey the rationale and cur-
rent use of this neuromodulation technique in a variety of
movement disorders and neuropsychiatric diseases.
*Correspondence: medmrd@emory.eduIn DBS procedures, stimulation electrodes are chron-
ically implanted into specific brain regions, and continu-
ous electrical high-frequency stimulation is delivered via
an implanted, externally programmable pulse generator,
similar to a cardiac pacemaker. The use of this tech-
nique for movement disorders was pioneered in the
1980s by Benabid, who first stimulated the thalamus
for essential tremor (ET) and tremor seen in PD. The sub-
thalamic nucleus (STN) was subsequently targeted for
PD, following the finding that STN lesions dramatically
reversed the motor signs of Parkinsonism in experimen-
tal animals. Although FDA approval has been given only
for ET and PD, the use of DBS has been extended to
other neurologic diseases and is now also being studied
for psychiatric disorders. The exact mechanism of ac-
tion of DBS remains uncertain, but the use of this
technique has brought dramatic and lasting benefits to
patients with an increasing number of disorders.
Basal Ganglia and Cerebellar Circuits
The reintroduction of surgical procedures like DBS was
guided by the growing understanding of the circuitry of
the basal ganglia and cerebellum, which were shown
to be components of larger brain circuits, and by the
realization that anatomically identifiable pathology in
these circuits could account for many of the motor, cog-
nitive, emotional, and motivational disturbances seen in
movement disorders, such as PD of dystonia, and some
of the neuropsychiatric disorders, such as Tourette’s
syndrome (TS) or obsessive compulsive disorder (OCD).
Modern models of these circuits, introduced in the
1980s based on physiologic and anatomical studies,
postulated that basal ganglia, thalamus, and cortex
are components of segregated, largely closed, reentrant
loop structures, which originate in specific cortical
areas, traverse the basal ganglia and thalamus in non-
overlapping regions, and then return to their respective
(frontal) areas of origin (Alexander et al., 1986). The
different circuits are commonly designated as ‘‘motor,’’
oculomotor,’’ ‘‘prefrontal,’’ and ‘‘limbic’’ (Figure 1). While
these terms do not adequately capture the complexity of
the functions subserved by these circuits, we will con-
tinue their use in this review for simplicity. It is thought
that all of the basal ganglia-thalamocortical circuits are
built following a similar general anatomical scheme,
which is shown in Figure 2. The figure also shows the
cerebello-thalamocortical system that functions (largely)
in parallel to the circuits traversing the basal ganglia.
DBS and other focal neurosurgical interventions appear
to work through selective effects on these cortico-sub-
cortical circuits. Common and experimental DBS targets
are indicated with asterisks in Figure 2.
DBS for Movement Disorders
The rationale for using DBS in movement disorders is
that these disorders arise at least in part from dysfunc-
tion within the basal ganglia-thalamocortical ‘‘motor’’
circuit. The motor circuit (Figures 1 and 2) originates
from pre- and postcentral sensorimotor fields and in-
volves the putamen (the motor portion of the striatum),
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198Figure 1. Circuit Anatomy of Cortex-Basal
Ganglia-Thalamocortical Circuits
Intrinsic anatomy of the basal ganglia-thala-
mocortical circuitry. Abbreviations: ACA, an-
terior cingulate area; CM, centromedian nu-
cleus of thalamus; CMA, cingulate motor
area; DLPFC, dorsolateral prefrontal cortex;
FEF, frontal eye fields; HD, Huntington’s dis-
ease; LOFC, lateral orbitofrontal cortex; M1,
primary motor cortex; MDpl, mediodorsal nu-
cleus of thalamus, pars lateralis; MOFC, me-
dial orbitofrontal cortex; Pf, parafascicular
nucleus of the thalamus; PMC, premotor cor-
tex; SMA, supplementary motor area; SEF,
supplementary eye field; VApc, ventral ante-
rior nucleus of thalamus, pars parvocellularis;
VAmc, ventral anterior nucleus of thalamus,
pars magnocellularis; VLm, ventrolateral nu-
cleus of thalamus, pars medialis; VLo, ventro-
lateral nucleus of thalamus, pars oralis; VLcr,
ventrolateral nucleus of thalamus, pars
caudalis, rostral division. See text for other
abbreviations.as well as motor portions of the external and internal pal-
lidal segments (GPe and GPi, respectively), the STN, and
the substantia nigra pars reticulata (SNr). GPi and SNr
are the basal ganglia output nuclei, projecting to por-
tions of the ventral anterior and ventrolateral nucleus
of the thalamus (VA and VL, respectively). Thalamocort-
ical projections from VA and VL to the frontal motor and
premotor areas close the motor circuit.
Parkinson’s Disease
PD is a progressive disorder with multiple etiologies, in-
cluding genetic and environmental factors. The primary
movement abnormalities in PD, collectively called par-
kinsonism, include slowness of movement (bradykine-
sia), tremor at rest, and muscular rigidity. These are
due to degeneration of dopaminergic neurons in the
SNc and their projections to the striatum, which second-
arily result in striatal dopamine depletion (Figure 2). At
least in the early stages of PD, the dopamine depletion
preferentially affects the motor circuit. In the most com-
mon form of parkinsonism, sporadic PD, the motor signs
are often accompanied by nonmotor features such as
depression, anxiety, autonomic dysfunction, sleep dis-
orders, and cognitive impairment. Although these may
result in part from dopamine loss in nonmotor basal gan-
glia circuits, it is believed that additional (nondopami-
nergic) pathology throughout the brainstem and fore-
brain contributes as well (Braak et al., 2003).
Dopamine depletion in the basal ganglia induces
prominent changes in neuronal activity within the motor
circuit. Thus, neuronal activity in GPi and STN has been
demonstrated to be increased in parkinsonian animals
and humans, and abnormal oscillatory activity and in-
creased synchrony of neuronal discharge has been ob-
served throughout all elements of the motor circuit (re-
cently reviewed in Gatev et al., 2006). While the link
between specific basal ganglia discharge abnormalities
and the behavioral manifestations of parkinsonism re-
mains uncertain, it is likely that some or all signs of par-
kinsonism arise from the fact that the abnormally pat-
terned basal ganglia output functionally disables
related thalamic and cortical areas. Functional imaging
studies have demonstrated that the changes in basal
ganglia activity are associated with abnormal activationpatterns in cortical motor (and other) areas both at rest
and with movement. DBS within the motor portions of
the STN or the GPi largely reverses these abnormalities.
DBS in GPi or STN. The most common indications for
surgery in PD are intractable tremor or drug-induced
motor fluctuations or dyskinesias. The best candidates
for DBS treatment in PD are patients with levodopa-
responsive parkinsonism who are free of significant
dementia or psychiatric comorbidities. In contrast, pa-
tients with atypical parkinsonism or dementia benefit
little, or not at all. Targets in the motor portion of GPi
or STN are currently preferred for DBS in PD. DBS is
most often performed bilaterally and simultaneously,
but unilateral DBS can be highly effective for asymmetric
cases. DBS in these areas alleviates parkinsonian motor
signs, particularly during ‘‘off’’ periods, and reduces the
often troublesome dyskinesias, dystonia, and motor
fluctuations that result from drug administration (Ander-
son et al., 2005; Rodriguez-Oroz et al., 2004; Weaver
Figure 2. Intrinsic Anatomy of Cortico-Subcortical Circuits
Inhibitory (GABAergic) connections are shown as red arrows, and
excitatory (glutamatergic) connections are shown as green arrows.
The basal ganglia are shown in the blue rectangle. Common and ex-
perimental DBS targets are marked with asterisks. PN, pontine nu-
clei. For other abbreviations, see legend to Figure 1 and text.
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199et al., 2005). Both procedures have been shown to
strongly improve the patient’s quality of life, and both
are more effective than medical management in the tar-
get population of patients with advanced PD (Deuschl
et al., 2006; Halbig et al., 2005). In contrast to patients
with GPi-DBS, those with STN-DBS are often able to
substantially reduce their medications (Rodriguez-
Oroz et al., 2004), which may, in part, account for the
antidyskinetic effects of this procedure. Although there
are no published blinded comparisons of the effects of
GPi- and STN-DBS, the STN is currently preferred by
most neurosurgeons because of its perceived greater
antiparkinsonian effect. Controlled clinical trials com-
paring the two targets are nearing completion.
The major surgical risk of suffering significant surgical
complications such as intracerebral hemorrhages is
small (1%–2%). However, stimulation itself may also
have side effects, including the induction of paresthe-
sias, involuntary movements, or cognitive and mood
changes. Many of these can be eliminated by adjusting
the stimulation parameters. Interestingly, GPi- and
STN-DBS differ in the incidence of cognitive and mood
side effects. Cognitive side effects, specifically reduced
lexical fluency and declines in executive functions (see,
e.g., Parsons et al., 2006; Troster et al., 1997), are more
often seen with STN-DBS than with GPi-DBS (Anderson
et al., 2005). Postoperative mood problems are also
more frequent after STN-DBS and include depression,
mania, anxiety, and apathy (Temel et al., 2006). These
side effects are likely caused by inadvertent stimulation
of limbic circuit elements in portions of the nearby zona
incerta, the ventral STN, or the SNr (e.g., Bejjani et al.,
1999; Stefurak et al., 2003).
In both types of DBS procedures, the basal ganglia
motor circuit is targeted, often through the use of intra-
operative microelectrode mapping of neuronal re-
sponses to passive and active movements. In GPi, the
motor territory is contained within the posterolateral
part of the nucleus, while for STN-DBS, the anterodorsal
border of the nucleus has been identified as the optimal
DBS target. DBS at this location is likely to reach a larger
proportion of the motor circuit within the much smaller
STN than DBS within the GPi motor area. This may
account for the perceived differences in effectiveness.
Stimulation at the ‘‘ideal’’ STN-DBS target may spread
to involve portions of the dorsally adjacent fields of Forel
and the zona incerta (e.g., Yelnik et al., 2003).
Although it was initially believed that DBS, like lesion-
ing, functionally inactivated the target, evidence now
suggests more complex mechanisms of action. The
electrophysiologic effects of GPi- or STN-DBS may de-
pend on the distance of the stimulated elements from
the electrode and may differ between the elements
themselves. Modeling studies have shown that STN-
DBS may inhibit the somata of STN cells through activa-
tion of local GABA release from GPe afferents, while
directly activating STN axons (McIntyre et al., 2004).
Stimulation in the STN has been demonstrated to evoke
complex excitatory effects in the GPi, one of the primary
recipients of STN efferents (Figure 2; e.g., Hashimoto
et al., 2003), and may alter oscillatory resonance charac-
teristics of the STN-GPi network (Brown et al., 2004).
Stimulation of GPi may directly activate the axons of
GPi cells. Both forms of DBS are likely to secondarilyalter firing patterns in the associated thalamocortical cir-
cuitry. In support of this idea, STN-DBS has been shown
to normalize intracortical inhibitory mechanisms in
transcranial magnetic stimulation studies (Pierantozzi
et al., 2002), and functional imaging studies have shown
that DBS induces widespread normalization of activity in
frontal motor areas both at rest and with movement
tasks (see Figure 3 and, e.g., Grafton et al., 2006).
Other DBS Targets in PD. Similar to other tremor
forms (see below), parkinsonian tremor can be effec-
tively treated with thalamic DBS at the border between
the thalamic nucleus ventralis oralis (Vop) and the nu-
cleus ventralis intermedius (Vim) (Kumar et al., 2003;
Ondo et al., 1998). Unfortunately, DBS at this location
does not provide consistent benefits to parkinsonian
signs other than tremor (Ondo et al., 1998) and is there-
fore appropriate for only a small minority of parkinsonian
patients (Obeso et al., 1997).
Several small studies have also described beneficial
results with extradural motor cortex stimulation (Pagni
et al., 2005). The procedure appears to result in im-
proved motor performance and reductions in dyskine-
sias and psychiatric symptoms, perhaps mostly be-
cause of reductions in medication requirements. A
recent primate study has confirmed the antiparkin-
sonian effects of motor cortex stimulation (Drouot
et al., 2004).
Figure 3. Effective DBS Normalizes Relative Cerebral Blood Flow
Patterns in Cortical Motor Areas in PD Patients
Plots of relative cerebral blood flow (rCBF; shown as means6 SEM),
measured with PET, in supplementary motor area (A) and prefrontal
cortex (B) in normal controls (n = 13), and in PD patients (n = 6) with
and without effective DBS. In all conditions, rCBF was measured at
rest (black columns) and with standardized arm movements (gray
columns). DBS normalized the activation of brain regions that were
underactive (A) or overactive (B) in PD, relative to healthy controls.
Data are from Grafton et al. (2006) and are used with permission.
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the brainstem has also been explored in PD. The PPN is
a major target of GPi output and projects back to the
STN as well as downstream (Figure 2; Mena-Segovia
et al., 2004). Inactivation of the PPN has been shown
to induce akinesia in animals (Kojima et al., 1997). Posi-
tive effects of low-frequency stimulation of the PPN
have been described in MPTP-treated monkeys (Nandi
et al., 2002b) and, recently, also in parkinsonian patients
(Plaha and Gill, 2005).
As mentioned elsewhere in this review, stimulation of
the region of the caudal ZI, just behind the STN, has sig-
nificant effects on parkinsonian tremor, as well as rigid-
ity and akinesia, reportedly rivaling those of STN-DBS
(Kitagawa et al., 2005; Plaha et al., 2006). At this location,
DBS may exert its antiparkinsonian activity through ef-
fects on ZI itself, but also on pallidofugal fibers to the
thalamus, which pass through the stimulated area.
Dystonia
Dystonia is characterized by involuntary twisting move-
ments, especially during attempted movement, as well
as abnormal postures, muscular agonist/antagonist co-
contraction, and ‘‘overflow’’ phenomena, where muscle
activation spreads beyond that intended. Dystonia can
occur in a primary form, i.e., without an identified struc-
tural or chemical abnormality, or as secondary dystonia,
due to drugs, brain lesions, or other movement disor-
ders, such as PD. Dystonia can also be classified into
generalized and focal forms. Generalized dystonia usu-
ally starts in childhood, while focal dystonia occurs more
commonly in adults, and may involve speech, eyelid clo-
sure, or neck or hand movements. While focal dystonias
can often be managed with botulinum toxin injections,
the medication treatments of generalized dystonia are
less effective.
Neuroimaging studies in dystonic patients have dem-
onstrated changes in portions of the motor circuit at
both cortical and subcortical nodes (Carbon et al.,
2004). Based on single-cell recording studies in pa-
tients, it appears that dystonia and PD are (grossly) sim-
ilar with regard to many of the pattern changes in basal
ganglia output. In contrast to PD, however, overall GPi
output appears to be reduced (Starr et al., 2005). In
cases of focal dystonia, there is electrophysiologic evi-
dence for reduced cortical inhibition, and aberrant orga-
nization of somatosensory cortical maps (Hallett, 2004).
These findings, together with the delayed effects of sur-
gery (see below), support the concept that abnormal
motor learning or excessive neuroplasticity may play
a role in dystonia.
DBS Surgery for Dystonia. The insight that dystonia
may arise from abnormalities in circuit elements shared
by parkinsonism and the past experience with ablative
procedures in dystonia have led to trials of GPi-DBS in
cases of advanced intractable dystonia. Recent case
reports suggest that STN-DBS may also be effective
(Pastor-Gomez et al., 2003).
GPi-DBS has excellent effectiveness in cases of gen-
eralized dystonia (Coubes et al., 2004; Eltahawy et al.,
2004; Vidailhet et al., 2005) but is less effective in sec-
ondary dystonia (e.g., Cif et al., 2003). Other emerging
indications for GPi-DBS are cervical and tardive dysto-
nia (e.g., Eltahawy et al., 2004; Loher et al., 2000; Trot-
tenberg et al., 2005). For unclear reasons, the effectsof GPi-DBS are usually delayed, often by weeks or
months (Krauss et al., 2002). While it can be speculated
that these delays involve anatomic or functional remod-
eling of neuronal interactions within the basal ganglia-
thalamocortical circuitry, no specific information regard-
ing this point is available. GPi-DBS for dystonia has few
(if any) cognitive side effects (Pillon et al., 2006). GPi-
DBS, administered to the motor portions of GPi, modu-
lates activity in the basal ganglia-thalamocortical motor
circuit. PET activation studies have shown that GPi-
DBS reverses the over-activity of motor cortical areas
present in dystonia (Detante et al., 2004), and electro-
physiologic studies have demonstrated that GPi-DBS
may enhance motor cortex excitability through modula-
tion of thalamocortical projections (Kuhn et al., 2003).
Tremor
A variety of tremor types, other than the rest tremor of
PD, are suitable for DBS, such as ET, cerebellar or inten-
tion tremor, and brainstem (Holmes) tremor. Tremor is
also seen in the setting of other disorders, such as dys-
tonia or multiple sclerosis. As mentioned before, tremor
was the first movement disorder to be treated routinely
with DBS, and it continues to be one of the major appli-
cations of this technique. DBS of the Vim nucleus of the
thalamus, a part of the cerebello-thalamocortical sys-
tem, appears to be effective for most forms of tremor
(regardless of etiology). The choice of this DBS target
was guided by the previous experience with Vim thala-
motomy procedures. Thus far, there is no unifying path-
ophysiologic hypothesis that would explain the almost
universal effectiveness of thalamic interventions in
these varied tremor disorders. Only recently, other tar-
gets have emerged as possible alternatives.
Essential Tremor. ET, the most common movement
disorder, is the prototypical action tremor, present with
both movement and posture. Despite the availability of
a number of effective medical treatments, the tremor re-
mains poorly controlled in a substantial portion of ET pa-
tients. For these patients, surgery is a viable treatment
alternative. The usefulness of Vim-DBS was serendipi-
tously discovered while physicians were performing tha-
lamotomies (Benabid et al., 1993). The optimal target for
Vim-DBS for ET treatment has been identified as the bor-
der of Vim and Vop (Yamamoto et al., 2004). Numerous
studies have confirmed that Vim-DBS reduces ET (Ku-
mar et al., 2003; Ondo et al., 1998). The procedure bene-
fits appendicular, vocal, and head tremor (e.g., Taha
et al., 1999). It significantly improves the quality of life
in ET patients (Fields et al., 2003) and remains beneficial
over time (Rehncrona et al., 2003), although some toler-
ance may develop (Kumar et al., 2003).
Vim-DBS has now almost replaced thalamotomy as
the surgical treatment of choice for ET, primarily be-
cause of its superior safety profile (Tasker, 1998). Al-
though most side effects are mild (Ondo et al., 1998),
persistent paresthesias and pain, and, in patients re-
ceiving bilaterally implants, dysarthria and balance diffi-
culties, appear to be rather common (Pahwa et al.,
2006). Vim-DBS has only minor effects on cognitive
functioning with slight declines in verbal fluency (Fields
et al., 2003).
The mechanisms that underlie the beneficial effects of
Vim-DBS in ET are unclear. In agreement with the fact
that Vim is part of the cerebello-thalamocortical circuitry
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bral blood flow in motor cortex and cerebellum is altered
by Vim-DBS (Ceballos-Baumann et al., 2001; Fukuda
et al., 2004).
Besides Vim surgery, DBS of the caudal zona incerta
region (discussed above, e.g., Kitagawa et al., 2000;
Murata et al., 2003) has recently been shown to be highly
efficacious in ET and other forms of tremor, especially
those with a prominent proximal limb involvement. Re-
cent case reports have suggested that DBS of the STN
may also be effective in some cases of ET, specifically
in cases in whom ET coexists with other movement
disorders, such as PD (Stover et al., 2005).
Tremor Associated with Multiple Sclerosis. Multiple
sclerosis is frequently associated with severe intention
tremor, most likely because of the predilection of demy-
elinating lesions for the cerebellar outflow tracts. Tha-
lamic DBS has proven to be at least partially effective,
especially in young patients with little comorbidity
(Berk et al., 2002; Moringlane et al., 2004). A recent anal-
ysis of 75 published cases of DBS in multiple sclerosis
came to the conclusion that the majority of patients
benefited from the procedures, although complete ces-
sation of tremor was rare (Wishart et al., 2003). As dis-
cussed above for ET, the caudal zona incerta target
appears to be beneficial for the treatment of tremor as-
sociated with multiple sclerosis (Nandi et al., 2002a).
Holmes Tremor and Other Tremor Forms. Holmes
tremor, resulting from brainstem lesions that affect cer-
ebellar outflow, is a combined rest, postural, and inten-
tion tremor. Only a small number of cases of this tremor
type have been treated with Vim-DBS (e.g., Romanelli
et al., 2003), and these cases have had excellent results.
Vim stimulation has also been used for other tremor
forms, often due to rare diseases, such as phenylketon-
uria (Payne et al., 2005) or inherited cerebellar ataxia
(Schramm et al., 2005).
DBS Use in Neuropsychiatric Disorders
The previous era of psychosurgery ended in the 1970s
because of severe condemnation of the excessive and
indiscriminate use of these procedures, their disap-
pointing outcomes, and the lack of patient protection.
It may seem surprising, then, that neurologists, neuro-
surgeons, and psychiatrists are again exploring surgical
procedures for severe psychiatric disorders, such as
OCD, TS, and depression. The acceptance of DBS is
due to several facts, including (1) the failure of existing
drugs to deal effectively with the psychiatric condition
in a subset of patients, (2) the remarkable success of
DBS procedures in treating movement disorders, (3)
the relatively less invasive and reversible nature of
DBS, (4) the greater public awareness of the enormous
lifelong burden of these disorders on patients and their
caregivers, and (5) the greater scrutiny and protection
of patient rights. DBS procedures for neuropsychiatric
conditions remain strictly experimental at this point.
Use of DBS in neuropsychiatric diseases is based on
findings suggesting that these conditions are, at least
partly, due to abnormalities within the nonmotor basal
ganglia circuits, most prominently the limbic circuitry.
As shown in Figure 1, the limbic circuit originates from
the anterior cingulate and medial orbitofrontal cortices;
engages the ventral striatum, the ventral and rostrome-dial GPi, and the rostrodorsal SNr; and continues to the
paramedian portion of the mediodorsal nucleus of the
thalamus, which projects back to the anterior cingulate
cortex. Under physiologic conditions, this circuit may
play a role in motivated behavior, and the modulation
of emotional ‘‘tone,’’ and may provide reinforcing stimuli
to the ventral tegmental area and the SNc.
Obsessive Compulsive Disorder
OCD is a relatively common disorder, characterized by
the presence of intrusive thoughts and compulsive be-
haviors and rituals. Selective serotonin reuptake inhibi-
tors are highly effective in the majority of patients, but
some severe cases are refractory and may benefit
from surgical treatments. Neurosurgical treatments of
OCD have been carried out for many years, using empir-
ically defined targets, e.g., the anterior limb of the inter-
nal capsule (IC). Lesions such as anterior capsulotomy
may benefit 35%–70% of these patients, but the irre-
versibility of lesions frequently deters patients from
this treatment option.
Case reports and small case series have shown that
the anterior limb of the IC is not only a lesioning target,
but also a target for DBS (Nuttin et al., 2003). The bene-
fits from the procedure are long lasting (Greenberg et al.,
2006). In most treated patients, few side effects are
seen. However, in a recent case report, a patient devel-
oped panic attacks with (presumed) ventral striatal (VS)
stimulation (Shapira et al., 2006). DBS of other areas,
such as the STN, is also currently being evaluated (Fon-
taine et al., 2004).
Functional imaging studies in OCD patients have dem-
onstrated abnormalities in the activity of limbic basal
ganglia-thalamocortical projection systems. Similar
studies have suggested that anterior capsule stimulation
works in OCD by influencing the activity in the nearby
limbic VS (e.g., Nuttin et al., 2003). In fact, in one OCD
patient treated with direct VS stimulation, long-lasting
benefits were seen (Aouizerate et al., 2004). A recent
PET imaging study has demonstrated that brain activity
during DBS of the VS/IC target is enhanced predomi-
nately in limbic areas of cortex, basal ganglia, and thala-
mus (Rauch et al., 2006).
Tourette’s Syndrome
TS is a familial, neurologic disorder characterized by
childhood onset of motor and vocal tics. The tics are
typically rapid, stereotyped movements with eye blink-
ing and head and facial movements, as well as vocaliza-
tions such as throat clearing, coughing, grunting, or
more complex behavioral acts and utterances. In addi-
tion, a high percentage of patients suffer from OCD, at-
tention-deficit hyperactivity disorder, depression, and
psychosocial difficulties, which are often more disabling
than the tics. Symptoms typically peak in preadoles-
cence and decline in the later teens for most patients.
In many patients, the tic disorder is effectively treated
with dopamine receptor antagonists, while the other
components of TS may require antidepressant and other
therapies. Based on imaging and other studies, TS ap-
pears to involve abnormalities in both the limbic and mo-
tor circuitry (see Figure 1), accounting for the complex
constellation of nonmotor and motor signs.
In a small proportion of TS patients, severe symptoms
persist into adulthood in spite of all therapeutic efforts.
Recently, reports of single cases or small case series
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targets have been used, including the midline intralami-
nar nuclei of the thalamus (Houeto et al., 2005; Temel
and Visser-Vandewalle, 2004; Visser-Vandewalle et al.,
2004), the motor and limbic portions of GPi (Houeto
et al., 2005), and the anterior limb of the IC, close to
the VS (Flaherty et al., 2005). The published reports de-
scribe that these procedures often result in >70% reduc-
tions in vocal or motor tics with disappearance of the
sensory urge that often accompanies TS, even long-
term. Before the use of these procedures can be recom-
mended for routine treatment in TS patients, careful ex-
ploration of the various targets and the development of
patient selection guidelines are mandatory (Mink, 2006).
Depression
Depression is one of the most common psychiatric dis-
orders. Most patients are treated with drug therapy and
behavioral therapies. Vagal nerve stimulation and elec-
troconvulsive therapy may be tried in cases of depres-
sion that do not respond. A small proportion of patients
nonetheless continue to suffer from severe intractable
depression.
Interestingly, signs and symptoms of severe depres-
sion can be (reversibly) induced in PD patients undergo-
ing DBS (e.g., Bejjani et al., 1999; Temel et al., 2006),
likely because of inadvertent stimulation of limbic por-
tions of the STN, the adjacent ZI, or SNr. The insight
that focal brain stimulation can profoundly alter limbic
function suggests that DBS of the limbic circuitry (at
other targets) could be used to treat depression in pa-
tients who suffer from intractable forms of the disease.
Although earlier single case studies have reported
that DBS of mesothalamic targets or of the inferior tha-
lamic peduncle is effective against reactive depression
in patients with chronic pain (Andy and Jurko, 1987), or
treatment-resistant major depression (Jimenez et al.,
2005), respectively, the precise target has not been
well defined. In a recent study involving six patients
with refractory depression, it has been shown that
DBS of the white matter in the subgenual cingulate re-
gion (area 25) can produce very significant clinical ben-
efits (Mayberg et al., 2005). This target was chosen after
a series of neuroimaging studies showed that area 25 is
overactive in depression (Mayberg et al., 1999). A region
in the rostral cingulate gyrus has also been proposed
as a possible target for DBS in depression (Sakas and
Panourias, 2006).
Conclusions
The insight that the signs and symptoms of several ma-
jor movement disorders and neuropsychiatric diseases
are, at least in part, due to dysfunction within specific
cortico-basal ganglia-thalamocortical circuits provides
a basis for understanding the pathophysiologic basis
of these disorders and has guided renewed trials of focal
surgical interventions for patients with medication-
resistant forms of these diseases. Because of its revers-
ibility and adjustability, DBS has rapidly become the
neurosurgical procedure of choice in these cases,
largely replacing ablation. For movement disorders, it
is proposed that DBS works by (nonspecifically) freeing
thalamocortical and brainstem motor systems from ab-
normal and disruptive basal ganglia influences. The
striking effectiveness of targeted focal surgical interven-tions such as DBS has lent further support for the exis-
tence of circuit disorders that result from pathology in
specific cortical-subcortical and other networks. Al-
though explorations of the pathophysiologic basis of
complex neuropsychiatric disorders such as TS, OCD,
and depression are just getting underway, preliminary
results suggest that DBS may also benefit selected ad-
vanced medically refractory cases of these conditions.
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